VWF and peripheral arterial disease: In comparison, 30.9% of patients with AS showed VWF:RCo/VWF:Ag of <0.7, while for patients with PAD and control patients, it was 14.8% (AS vs PAD; P = .09) and 0.0% (patients with AS vs control patients; P < .001), respectively (Figure 2C, F, and I).